EPA Indicates It Will Finalize Proposed PFAS Reporting Exemptions

EPA is signaling that it intends to significantly narrow the scope of the Toxic Substances Control Act (TSCA) PFAS reporting rule by finalizing key exemptions as proposed.

The Agency disclosed its intentions in a routine notice concerning the rule’s information collection request (ICR). Published November 13, 2026, the notice discusses the anticipated changes to reporting burdens under the revised rule.

EPA intends to “incorporate the following exemptions to the scope of reportable manufacturing activities: a de minimis exemption of 0.1%; imported articles; byproducts; impurities; research and development (R&D) chemicals; and non-isolated intermediates,” the notice states.

Those exemptions are the same exemptions proposed by EPA in November 2025. According to the notice, they will reduce the number of affected entities from 131,411 to just 255. EPA also projects a reduction of 3.4 million reporting hours and a decrease in the number of required reports from 67,548 to 1,461.

Although the notice provides a strong indication of EPA’s intended approach, the exemptions are not yet final. The proposed amendments have yet to be received by the Office of Management and Budget (OMB), a required step before publication of the final rule. This suggests that publication of the final rule is not imminent.

EPA faces a relatively tight timeline, however, because the reporting window is currently set to begin January 31, 2027. The revisions would replace that start date with a three-month reporting window beginning 60 days after the rule’s effective date.

The November 13 notice concerns EPA’s submission to OMB of a proposed extension of the ICR associated with the existing rule under the Paperwork Reduction Act. EPA notes that the revised reporting requirements will be submitted as a separate ICR action once the amendments are finalized.

Comments on the notice will be accepted through December 14, 2026.

EPA Releases First Agency-Wide PFAS Technology Strategy

On October 26, 2026, EPA released its first-ever agency-wide PFAS Technology, Evaluation, Coordination, and Harmonization (PFAS TECH) strategy. The strategy aims to address PFAS contamination through technology development and collaboration with federal partners, states, local leaders, and the private sector.

“This new effort will help catapult technology innovation on PFAS while supporting practical tools, funding, and technical assistance to benefit communities addressing local PFAS challenges,” EPA said in a press release.

The strategy, which is largely a compilation of existing and planned projects, has three overarching goals:

  1. Powering innovation in research and development. EPA will facilitate public-private partnerships to promote analytical method development and emerging technologies to remove PFAS from drinking water. EPA offices will also coordinate on organomineral and anaerobic digestion techniques for PFAS destruction and evaluate supercritical water oxidation, a process that EPA reports destroyed more than 99.99% of PFAS in firefighting foam at industrial scale.
  2. Demonstrating What’s Possible through Pilot-Scale Initiatives. EPA highlights partnerships with about 40 drinking water utilities to identify optimal treatment methods. The strategy also notes potential pilot projects with the Department of War and Department of Energy on emerging destruction technologies and a future framework for managing soil containing low concentrations of PFAS.
  3. Translating Progress into Practical Actions. EPA plans to publicly release a searchable tool for identifying appropriate destruction and disposal methods, called the PFAS Break the Bond Navigator. The tool will be updated on a rolling basis as EPA evaluates these technologies.

The strategy indicates that new R&D funding for PFAS destruction is coming through EPA’s Science to Achieve Results (STAR) grant program and Small Business Innovation Research programs. It also points to infrastructure law money for PFAS treatment, especially for small and rural systems.

According to the strategy, National Program Offices and Regional Offices will advance these actions over the next two years. EPA encourages interested parties to get involved by contacting PFASTECH@epa.gov.

Lawmakers Ask GAO to Review EPA’s Microplastics Research and Regulatory Efforts

Following EPA’s decision not to list microplastics in the proposed Sixth Unregulated Contaminant Monitoring Rule (UCMR 6), two dozen Democratic lawmakers are asking the Government Accountability Office (GAO) to review the Agency’s efforts to assess human exposure to micro- and nanoplastics and their associated risks.

“Congress lacks a clear assessment of what the EPA has accomplished in its work on microplastics and what work remains necessary to support reliable monitoring, risk assessment and potential regulatory action,” the letter, dated September 28, 2026, states.

The letter cites EPA plans to evaluate and address microplastic pollution, including EPA’s Safe and Sustainable Water Resources (SSWR) Strategic Research Action Plan for fiscal years 2023-2026 and its 2024 National Strategy to Prevent Plastic Pollution. According to the letter, those initiatives outlined plans to assess the effects of microplastics on human health and aquatic life, develop government-wide definitions, and standardize methods for quantifying microplastics. However, the lawmakers note uncertainty over the extent to which EPA has achieved these objectives.

The letter also challenges EPA’s exclusion of microplastics from the proposed UCMR 6, which the Agency justified by the lack of a validated analytical method for quantifying microplastics. The lawmakers note that EPA reported two years ago that it was in the early stages of developing such a method.

“Notably, the EPA has not scientifically justified, or even stated, that microplastics are less of a public health threat than any of the 30 other contaminants they included on the draft UCMR,” which is required by law, it adds.

The letter is led by Reps. Janelle Bynum (D-OR), Raja Krishnamoorthi (D-IL), and Watson Coleman (D-NJ). Sen. Merkley (D-OR) is the only senator among the signatories.

Questions for GAO

The letter outlines three questions for GAO to investigate.

First, it asks what microplastic- and nanoplastic-related activities the EPA has undertaken since fiscal year 2023. The request covers research, analytical method development, monitoring, risk assessment, pollution prevention, development and evaluation of capture and removal technologies, grant programs, and regulatory and other policy activities.

Second, it asks the extent to which EPA implemented the microplastics-related goals, outputs, and actions identified in the SSWR plan and 2024 National Strategy to Prevent Plastic Pollution. Specifically, the letter asks GAO to examine:

  • EPA’s progress towards developing government-wide definitions and validated, fit-for-purpose methods for collecting, extracting, identifying, quantifying, and characterizing microplastics and nanoplastics;
  • Research conducted or supported by EPA on the prevalence, sources, pathways, fate, and concentrations of microplastics and nanoplastics, and resulting findings;
  • EPA research on the toxicity of micro- and nanoplastics in human and aquatic life and resulting findings;
  • Methods, models, and tools developed or investigated by EPA to evaluate the effects of microplastics and nanoplastics on human health and aquatic resources and resulting findings;
  • EPA’s progress in developing testing, demonstrating, deploying, or funding management practices and technologies to prevent, capture, or remove microplastics and nanoplastics from the environment. This includes interventions to support these technologies and evaluations on the use of relevant water programs to address plastic pollution in waterways and oceans;
  • EPA’s implementation of policy and program opportunities identified in the national strategy, including evaluating the use of Clean Water Act (CWA) authorities and providing technical assistance to incorporate plastic pollution prevention, capture, and removal measures into relevant management plans.

Third, it asks what statutory, financial, workforce, technological, or infrastructure constraints affect EPA’s ability to advance its work of researching and regulating microplastics.

More information on EPA’s microplastics research can be found on EPA’s website.

Federal Recyclability Labeling Bill Would Impose National Criteria, FTC Enforcement

In August, Senator Jeff Merkley (D-OR) and Representative Lou Correa (D-CA) introduced bicameral legislation that would establish national criteria and standardized labels for marketing packaging, food service products, and beverage containers as recyclable, compostable, reusable, or refillable.

H.R. 10048 and S. 5302, both introduced August 6, 2026, are House and Senate companion versions of the Truth in Labeling Act of 2026 and are substantively identical, aside from minor textual differences.

The House version has been referred to the House Committee on Energy and Commerce, and the Senate version has been referred to the Senate Committee on Commerce, Science, and Transportation.

Purpose and Findings

The Truth in Labeling Act states that there is significant consumer confusion about which covered materials are recyclable, compostable, reusable, or refillable, and identifies inconsistent labeling and improper use of the chasing arrows symbol as sources of consumer confusion. The legislation also states that the Federal Trade Commission’s (FTC’s) Green Guides are outdated and do not provide sufficient information to establish labeling criteria at the national level.

According to the bill’s sponsors, unclear or misleading labels can result in materials being placed in the wrong waste stream, contributing to contamination and making recycling and composting systems less effective.

The legislation is intended to create consistent national standards so that environmental labeling claims better reflect how materials are actually collected and processed.

What the Bill Would Do

The Truth in Labeling Act would establish nationwide definitions and labeling standards for the terms “recyclable,” “compostable,” “reusable,” and “refillable.” The requirements would apply to covered materials: packaging, food service products, and beverage containers. They apply when a producer chooses to label a covered material or is contractually obligated to. A producer is the person who affixes, or directs another to affix, a chasing arrows symbol, label, or other marking indicating recyclability, compostability, reusability, or refillability. It also includes a person who later modifies a properly labeled material so that it no longer qualifies.

A covered material that does not meet the applicable criteria could not display a label or marking, including the chasing arrows symbol or its equivalent, that would lead an ordinary consumer to believe the material is recyclable, compostable, reusable, or refillable.

EPA, in coordination with the FTC and with input from an advisory committee the bill would create, would issue regulations for determining whether a covered material meets the criteria. For recyclability and compostability, it would also describe acceptable qualified claims. EPA would also be required to establish or approve standardized on-package labels within two years of enactment. The standardized labels would include harmonized terminology and iconography and could be supplemented by standardized digital labels, such as QR codes.

EPA would also publish lists of covered materials that meet the criteria.

Recyclable Criteria

A covered material would be considered “recyclable” if it:

  1. Is made in accordance with the design guidelines of the relevant industry, if approved by the EPA Administrator;
  2. Does not include any components, including inks and adhesives, that prevent the material from being recycled, unless it includes on-package instructions describing how to remove and properly dispose of a separable component;
  3. Is collected, separated, or otherwise recovered from the waste stream through an established recycling program for which a responsible end market exists that covers at least 60% of consumers or communities where the item is sold; and
  4. Has a commercial value for recycling and a responsible end market.

A covered material that only meets criteria 1, 2, and 4 may still be eligible for a qualified recyclability claim, provided that:

  • The recycling program covers at least 40% of consumers or communities; and
  • The EPA Administrator has approved a plan for the covered material to be considered recyclable within two years of approval.

Converting covered materials into fuel, or using them to generate electricity, heat, or steam, would not be considered recycling and would not count toward the 60% or 40% thresholds.

The bill would also require all plastic covered materials to bear a resin identification code. The code could not be placed inside a chasing arrows symbol unless the material meets the recyclability criteria and inside placement is the only physically feasible placement, as determined by EPA. This provision would preempt any conflicting state requirement.

Compostable Claims

A covered material would be considered “compostable” if it:

  1. Is designed to be compostable in accordance with the design standards and guidelines of its industry;
  1. Adheres to ASTM International 6400, 6868, or equivalent standard specifications, and does not contain intentionally added PFAS or heavy metals incompatible with compost;
  2. Is capable of being collected and accepted by at least 50% of the established composting programs in the US; and
  3. Is processed by itself or with other covered material categories through controlled biological degradation to make compost or a substantially similar soil amendment.

A covered material that is capable of being collected and accepted by at least 30% of the established composting programs in the US and meets criteria 1, 2, and 4 would be eligible for a qualified claim.

The legislation also specifically prohibits non-compostable plastic or plastic-lined covered material from marketed in a way that might mislead the public, such as green or brown tinting or coloring.

Reusable and Refillable Claims

A covered material could be labeled “reusable” or “refillable” if it:

  1. Is designed to be reusable or refillable in accordance with the relevant industry design standards and guidelines;
  2. Is designed for durability and maintenance to extend the useful life of the covered material and to reduce demand for new production of the covered material;
  3. Can be recirculated or refilled multiple times for the same or a similar purpose in the original format of the covered material;
  4. Is supported by a system or physical infrastructure that is in place to ensure the possibility and likelihood of reuse or refill, provided by a producer or a third party, and designed for convenient reuse or refill; and
  5. is not intended for single use by a consumer.
Deadlines and Enforcement

Enforcement would begin two years after EPA establishes or approves the standardized labels, which are themselves due within two years of enactment. After that, selling, using, distributing, or importing a covered material in violation of the Act would be a deceptive practice under the FTC Act.

The legislation would make exceptions for covered material manufactured more than six months prior to that date. It makes similar exceptions if the criteria are changed and provides a safe harbor for materials on EPA’s published lists.

Apart from the resin identification code provision, the bill would not preempt state law.

State-Level Litigation

The proposed federal standards come as similar recyclability labeling requirements face legal challenges at the state level. As discussed in a previous post, a federal court recently blocked on a preliminary basis enforcement of California’s “Truth in Recycling” law after concluding that challengers were likely to succeed on First Amendment and vagueness claims.

Among other requirements, California’s law generally required products and packaging to satisfy a “60/60” standard for collection and processing before recyclability claims could be made. The Truth in Labeling Act similarly incorporates a 60% threshold into its federal recyclability criteria, although the federal proposal establishes a different regulatory framework and expressly provides for qualified recyclability claims at a lower threshold.

EPA Seeks Scientific Input as Glyphosate Review Moves Forward

EPA’s long-running review of glyphosate is entering a new phase, with the Agency soliciting scientific input and working with the Department of Health and Human Services (HHS) to reassess the pesticide’s potential effects on human health.

Last month, EPA requested comment on a list of studies that will inform its ongoing registration review of the pesticidal substance under the Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA). This month, the Agency also announced a partnership with HHS to improve scientific coordination in the review.

Although FIFRA requires EPA to review pesticide registrations at least every 15 years, the Agency has not yet completed the registration review that began in 2009. The review has been prolonged, in part, by the Ninth Circuit’s 2022 vacatur of the human-health portion of EPA’s interim decision.

Glyphosate is best known as the active ingredient in the weed-killer Roundup. EPA has long taken the position that glyphosate is not a human carcinogen, a position shared by a number of other international regulatory authorities. However, in 2015, the International Agency for Research on Cancer (IARC) classified glyphosate as “probably carcinogenic to humans.”

IARC’s determination was a major catalyst for litigation over Roundup’s alleged carcinogenicity. Nearly 4,000 actions are currently pending in a federal multidistrict litigation concerning Roundup product liability claims, with numerous state suits also pending.

Those plaintiffs were dealt a significant blow earlier this year by the Supreme Court. In Monsanto Co. v. Durnell, the Court held that FIFRA preempts state-law failure-to-warn claims based on the absence of a cancer warning from EPA-approved Roundup labels.

EPA’s registration review could have significant implications for this ongoing litigation. And because glyphosate is one of the most widely used pesticides in the United States, the review may also have significant agricultural implications.

Background on EPA’s Glyphosate Review

In 2020, EPA issued an interim registration review decision concluding that glyphosate posed no human-health risks of concern when used according to its label and was “not likely to be carcinogenic to humans.” Environmental and farmworker organizations challenged that decision in the Ninth Circuit. In Natural Resources Defense Council v. EPA, the court vacated the human-health portion of EPA’s interim decision and remanded it to the Agency for further analysis and explanation.

The court held that EPA’s selection of the “not likely to be carcinogenic to humans” hazard descriptor was not supported by substantial evidence because its reasoning was internally inconsistent and did not adequately follow the Agency’s Cancer Guidelines. Among other concerns, EPA acknowledged that the available evidence did not permit a conclusion regarding the association between glyphosate exposure and non-Hodgkin lymphoma, but nevertheless classified glyphosate as “not likely to be carcinogenic to humans.” The court also identified problems with EPA’s evaluation of animal-tumor studies. The court did not determine that glyphosate causes cancer; rather, it concluded that EPA had not adequately supported its classification.

The Ninth Circuit also held that EPA’s registration review decision constituted agency action triggering the requirements of the Endangered Species Act (ESA). It remanded the ecological portion of the decision without vacatur and directed EPA to complete additional review.

In September 2022, EPA withdrew the remaining portions of the interim decision, explaining that it needed additional time to address the ecological issues and satisfy its ESA obligations. EPA stated that its underlying scientific findings had not changed but that it would revisit and better explain its evaluation of glyphosate’s carcinogenic potential.

Open-Literature Search

On August 25, 2026, EPA released a list of studies screened by the Agency to inform its human health risk assessment for glyphosate. The list includes over 5,300 studies, including over one thousand studies classified as “potentially relevant.” In a separate document, EPA explained the methodology underlying the search.

The same day, EPA requested public input on the completeness of the search and asked commenters to identify additional peer-reviewed studies that may warrant consideration. The Agency initially established a September 24, 2026, deadline for comments.

On September 28, EPA extended the comment period on its search by 60 days, moving the deadline from September 24 to November 23, 2026. According to EPA, the extension is intended to provide additional time for meaningful stakeholder input.

EPA-HHS Memorandum of Understanding

On September 22, 2026, EPA and HHS announced a new interagency memorandum of understanding (MOU) intended to expand scientific coordination in EPA’s glyphosate registration review. Under the agreement, the agencies will exchange scientific information, identify research gaps, and coordinate additional research concerning potential human health effects of glyphosate.

EPA and HHS will establish a joint technical working group composed of experts from EPA’s Office of Pesticide Programs and several HHS components, including the National Institute of Environmental Health Sciences, National Toxicology Program, National Cancer Institute, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention’s National Center for Environmental Health, and the Food and Drug Administration.

The agencies identified several areas for additional research and coordination, including the toxicology of glyphosate formulations and surfactants, occupational epidemiology, human exposure and biomonitoring, and dietary exposure. EPA stated that its updated human health assessment will evaluate evidence concerning cancer, genotoxicity, reproductive and developmental effects, as well as exposure from glyphosate-based formulations, occupational uses, and dietary sources, including preharvest applications.

The MOU creates no new authority for either agency and does not dictate the outcome of the registration review. EPA retains sole responsibility for registration decisions under FIFRA.

What to Watch

EPA currently anticipates completing the updated human health risk assessment in early 2027. That assessment will provide another opportunity for public comment and could inform subsequent regulatory decisions concerning glyphosate. In the meantime, under the MOU, EPA and HHS intend to make appropriate materials produced by the working group available in the glyphosate registration-review docket as they are finalized.

In addition, the first Roundup trial following Durnell is currently underway. While state-law failure-to-warn claims are no longer viable, the trial may be an early indicator of whether design defect or other torts can succeed. That case is Aretino v. Monsanto Co., No. 20SL-CC03676 (Mo. Cir. Ct., St. Louis County), filed July 10, 2020.

Interagency MOU Addresses Chemical Contaminants in Meat, Poultry, and Egg Products

In a move described as advancing the Make America Healthy Again (MAHA) initiative, the Department of Agriculture (USDA), Department of Health and Human Services (HHS), and EPA have updated a memorandum of understanding (MOU) addressing drug residues, pesticide residues, and chemical contaminants in meat, poultry, and egg products.

Announced July 10, 2026, the MOU is intended to coordinate federal activities concerning chemical residues and contaminants that have the potential to adulterate those foods. It supersedes a prior 1984 agreement between the same agencies.

According to a USDA press release, as part of the effort, USDA’s Food Safety and Inspection Service (FSIS) has implemented a new laboratory method to monitor levels of 18 heavy metals in foods. USDA says that elevated levels will lead to further assessment and possible regulatory response. The press release adds that FSIS will “expand its surveillance for heavy metals to include processed foods, such as sausages and ready-to-eat meals, which combine ingredients from multiple sources.”

Coordinating Federal Oversight of Chemical Residues

FSIS primarily oversees the safety and regulation of meat, poultry, and egg products and tests these products for chemical residues through programs such as the National Residue Program. FDA oversees most other foods, live food-producing animals before slaughter, animal food, and animal drugs. EPA regulates pesticides and establishes allowable pesticide residue levels in food, including food for food-producing animals.

Under the MOU, FSIS, FDA, and EPA will coordinate on sampling and testing, tolerances and screening levels, and potential regulatory violations. Among other things, FSIS will provide FDA with weekly residue reports and keep FDA and EPA informed of its sampling and testing programs. FDA and EPA will also notify FSIS when they establish or amend certain tolerances, exemptions, action levels, or safe levels that may relate to FSIS-regulated products.

The agencies also agree to notify one another of information concerning the actual, suspected, or anticipated presence of chemical residues or contaminants that may constitute or result in violations of applicable federal food safety laws. FDA will review reports of potentially adulterated food and, when appropriate, investigate the circumstances that may have caused food-producing animals to be exposed before slaughter. EPA will similarly review reports of pesticide misuse or other potential violations and, when appropriate, investigate or refer the matter to the appropriate state enforcement authority.

A Senior Executive Council with representatives from each of the three agencies will oversee the arrangement and meet at least annually. The MOU also establishes procedures for sharing confidential and non-public information among the agencies, subject to applicable confidentiality requirements.

EPA Finds Unreasonable Risk in Four Draft TSCA Risk Evaluations

In August and early September, EPA released draft risk evaluations for 1,2-dichloropropane, trans-1,2-dichloroethylene, o-dichlorobenzene (oDCB), and p-dichlorobenzene (pDCB) under the Toxic Substances Control Act (TSCA). EPA preliminarily determined that all four substances present unreasonable risk, driven primarily by certain conditions of use analyzed in the draft risk evaluations.

EPA will consider public comments before finalizing the evaluations. If EPA continues to find unreasonable risk, the agency will propose risk management actions under TSCA Section 6(a) to address those exposures.

1,2-Dichloropropane

1,2-Dichloropropane is an industrial chemical used in laboratory and industrial applications. According to EPA, it was previously used in cleaners, polishes, and waxes, and the Agency is evaluating those uses because imported products may still contain the substance. EPA has recognized 1,2-dichloropropane as likely to be carcinogenic to humans.

EPA’s draft evaluation identifies significant contributions to unreasonable risk to workers and occupational non-users from inhalation and dermal exposure under 11 conditions of use. Three consumer uses involving cleaners, polishes, and waxes were also preliminarily found to contribute to unreasonable risk. EPA did not identify unreasonable risk to the general population or the environment.

trans-1,2-Dichloroethylene

trans-1,2-Dichloroethylene is used in industrial and commercial cleaning and degreasing, as a processing aid, and in consumer products such as cleaners, degreasers, and foam insulation.

EPA’s draft evaluation identifies significant contributions to unreasonable risk to workers and occupational non-users from inhalation exposure under 19 conditions of use. One consumer use of trans-1,2-dichloroethylene—as a cleaner or degreaser—was also preliminarily found to contribute to unreasonable risk. EPA did not identify unreasonable risk to the general population or the environment.

oDCB and pDCB

oDCB and pDCB are used in household and commercial products and can evaporate into the air. pDCB is used in some air-care and deodorizing products, making indoor air a potential route of consumer exposure.

EPA’s draft evaluation for oDCB identifies contributions to unreasonable risk to workers from 14 conditions of use through inhalation, with dermal exposure contributing to risk in seven conditions of use. The draft also identifies unreasonable risk to consumers from one condition of use through inhalation.

For pDCB, EPA identified contributions to unreasonable risk to workers from seven conditions of use through inhalation and dermal exposure, as well as to consumers through inhalation from air-care products.

For both substances, EPA evaluated developmental, liver, and respiratory toxicity. EPA’s worker risk estimates do not assume the use of personal protective equipment (PPE), although the draft evaluations separately discuss how PPE and other controls could reduce exposure. EPA did not identify unreasonable risk to the general population through ambient outdoor air, including fenceline communities, or to the environment.

EPA’s draft evaluation for pDCB also concludes that the substance is not likely to be carcinogenic to humans. EPA acknowledges, however, that the International Agency for Research on Cancer and the National Toxicology Program have classified pDCB differently. EPA is specifically seeking comments and data on its assessment.

What This Means in the Context of EPA’s TSCA Evaluations

EPA is behind schedule on legally required risk evaluations under TSCA. In November 2024, EPA entered into consent decrees with the D.C. District Court concerning 22 risk evaluations, none of which were completed within TSCA’s 3.5-year deadline. The consent decrees created a court-enforceable schedule for EPA to complete the overdue evaluations.

The consent decrees have since been modified. In March 2025, EPA asked the court to extend by 60 days the deadlines for two draft risk evaluations and the final risk evaluation for 1,1-dichloroethane. The court granted the extensions on March 7, 2025.

The release of these four draft evaluations reflects EPA’s continuing effort to complete years-overdue TSCA risk evaluations under the court-ordered schedule established to address the Agency’s backlog.

Ninth Circuit Upholds EPA’s 2024 New Chemicals Rule

Less than two weeks after oral argument, a Ninth Circuit panel has denied consolidated challenges to EPA’s 2024 rule governing reviews of new chemicals under the Toxic Substances Control Act (TSCA).  The ruling upholds EPA’s case-by-case evaluations of persistent, bioaccumulative, and toxic substances (PBTs) for streamlined new-chemical reviews.  It also upholds the Agency’s decision not to address a comment from workers’ unions advocating greater transparency around the substances to which workers are exposed.

The 2024 New Chemicals Rule

On December 18, 2024, EPA published a rule revising its new chemical review regulations for the first time since Congress substantively amended TSCA in 2016.  Some revisions were designed to align the regulatory text with the 2016 amendments, while others addressed EPA’s procedures for reviewing new chemical applications.

At issue in the case, the rule narrowed eligibility for the Low Volume Exemption (LVE) and Low Releases and Low Exposures (LoREX) exemption.  These exemptions are streamlined alternatives to the lengthy premanufacture notice (PMN) process typically required before a TSCA-regulated substance may be introduced into commerce.  Under 40 CFR § 723.50(d)(2), PFAS are categorically ineligible for both exemptions, and PBTs are ineligible if they have “anticipated environmental releases and potentially unreasonable exposures to humans or environmental organisms.”

In the rule, EPA characterized the eligibility restrictions for PBTs as consistent with existing policy and stated that it “expects that most exemptions for PBT chemical substances will not be granted.”  The Agency also noted that it had denied all LVE notices for PFAS submitted since 2021.

Environmental and Workers’ Union Challenges

The rule was separately challenged by environmental groups and a workers’ union.

The environmental groups—Alaska Community Action on Toxics and the Environmental Defense Fund—argued that the rule did not go far enough, contending that PBTs should be categorically ineligible for the LVE and LoREX exemptions.  In their opening brief, they argued that TSCA Section 5(h) only allows EPA to create exemptions if its terms ensure that the substance “will not present an unreasonable risk.”  Because EPA “recognize[s] that new PBTs are inherently risky,” they alleged that EPA acted arbitrarily and exceeded its authority by declining to make all PBTs ineligible.  The groups further argued that the regulatory scheme “turns the statute on its head” by making PBTs presumptively eligible unless EPA affirmatively determines that the substance could result in potentially unreasonable exposure.

By contrast, the union—United Automobile, Aerospace and Agricultural Implement Workers of America (UAW)—challenged the rule for what it failed to address.  During the rulemaking, UAW and other unions jointly filed a comment describing the difficulties workers and unions face in determining the substances workers are exposed to, arguing it means that unions cannot weigh in on appropriate worker protections or confirm that employers are complying with restrictions.  In its lawsuit, UAW argued that EPA failed to consider the comment in violation of the Administrative Procedure Act (APA) and contrary to Congress’s intent that “the new chemical review process be transparent.”

The challenges were filed shortly before the presidential transition.  After obtaining a stay to consider the rule, the incoming Trump administration decided to defend it.

The Ninth Circuit’s Ruling

The Ninth Circuit denied both petitions in its seven-page, not-for-publication disposition issued August 26, 2026.

Addressing the environmental groups’ arguments first, the court held that TSCA delegates discretionary authority to EPA.  Section 5(h) allows EPA to consider exemptions “upon application,” the court explained, so case-by-case evaluations of PBTs are permissible.  The panel also concluded that EPA’s decision is not arbitrary and capricious because EPA considered and rejected the environmental groups’ preferred approach.  “Because the PBT Regulation governs new chemical substances, including those not yet developed, it was reasonable for EPA to reject a categorical ban,” the disposition states, noting heightened deference to agencies making predictive or scientific judgements.

As for UAW, the court held that the unions’ comment was only “tangential” to the proposed rule.  “The only aspect of EPA’s proposed rule that UAW cited was EPA’s proposal to change how certain scientific information would be made public,” but “UAW’s comment did not discuss the relative benefits of publication through either medium or address any matter germane to EPA’s proposed rule,” so EPA could lawfully decline to address the comment, the court held.

The case is Alaska Community Action on Toxics v. EPA, No. 25-158 (9th Cir.), docketed January 10, 2025.

EPA’s Battery-Cathode SNURs Test the Limits of “Significant New Use”

EPA has proposed two significant new use rules (SNURs) under the Toxic Substances Control Act (TSCA) that would extend restrictions across the full lifecycle of the cathode substances in lithium-ion batteries, including recycling and reclamation.  Industry stakeholders note that this is a departure from ordinary SNUR practice.  The rules, published on April 24, 2026, cover two generically identified “cobalt lithium manganese nickel oxide, metals-doped” substances used as cathode active materials (CAMs) in lithium-ion batteries.  The comment period, extended once, closed July 10, 2026.  As of this writing, EPA has not finalized, withdrawn, or re-proposed the rules.

What the Proposal Would Do

Under the proposed rules, EPA would regulate the CAMs even after the substances have been manufactured into articles.  Usually, the agency exempts substances in articles from SNUR obligations.

The proposed rules impose a labeling requirement for the articles—the batteries—that contain these substances.  In addition, recycling and reclamation restrictions would apply when the batteries are shredded or otherwise handled in a manner that generates dust.  These restrictions include 99% dust-control efficiency, no release to water, hazardous-waste disposal, and respiratory protection.  In other words, it would be a significant new use to manufacture, process, recycle, or reclaim the material without these controls.

The Federal Register notice explained that the proposed SNURs merely extend restrictions from the Section 5(e) consent orders imposed on the original premanufacture notice (PMN) submitters to all manufacturers and processors.

Why the Approach is Contested

Comments on the proposed rule assert that much of what EPA proposed is impracticable if not impossible.  The Alliance for Automotive Innovation argued that the proposed SNUR would “impose responsibility for the future management of individual chemical constituents throughout a downstream recycling infrastructure that is outside of the manufacturer’s ownership or control.”  Their comments note that while such regulation may be permissible under TSCA, regulating an article through its lifecycle base on the chemicals within the article is not the intent of the statute.

The Chemical Users Coalition—whose members include Airbus, Boeing, Intel, Lockheed Martin, and RTX—asked EPA to withdraw the proposal.  Their comments argued that the terms “processing” and “use” are unclear as applied to repair, import of batteries containing the SNUR substances, either by themselves or as part of larger articles, and recycling.  In addition, according to the Coalition, EPA failed to satisfy the threshold requirement of TSCA Section 5(a)(5) which requires that the Administrator make an affirmative finding that the reasonable potential for exposure to the chemical substance through the article “justifies notification” before imposing a SNUR for the “import or processing of a chemical substance as part of an article.  The Coalition also flagged that it is possible that there are ongoing uses of the substance that would not have been subject to TSCA Section 5 notice requirements—e.g., the import of the substances when incorporated into an article and the subsequent recycling of such articles.  This, the Coalition argues, was not addressed in the proposed rule.

Who is Affected, and What to Watch

The proposed rule reaches broadly beyond chemical manufacturers to battery producers, automakers, and recyclers, and importers of batteries and battery-containing articles. The regulation would be especially onerous for importers.  In most cases chemical composition of articles is not readily available, which may make it hard to know whether an imported battery contains a covered substance or if one needs to request an applicability determination from the supplier.

If the final rule keeps the article and recycling requirements in their current form, industry is likely to challenge the agency’s statutory authority for the rulemaking.

CSB Renews Calls to Expand EPA RMP and OSHA PSM Coverage of Reactive Hazards

In July 2026, the U.S. Chemical Safety and Hazard Investigation Board (CSB) published its investigation report concerning chemical decomposition, fires, and a toxic gas release at the Bio-Lab Conyers facility in Conyers, Georgia. The report calls for revisions to OSHA’s Process Safety Management (PSM) standard and EPA’s Risk Management Program (RMP) rule to cover reactive hazards and prevent similar incidents.

The Incident

On the morning of September 29, 2024, the Bio-Lab Conyers facility experienced a chemical reaction involving hazardous chemicals that caused extensive off-gassing, excessive heat generation, multiple fires, and a large plume of toxic smoke containing chlorine, hydrogen chloride, bromine, and other substances. These conditions prompted shelter-in-place orders, evacuations, and road closures by local authorities. Roughly 17,000 people in the surrounding community were evacuated, and local media reported that 90,000 people in the Atlanta metropolitan area were advised to shelter in place due to toxic smoke from the fires.

The CSB determined that the incident began when water from a failed sprinkler-system component contacted chlorinated isocyanurates stored in the warehouse, initiating a decomposition reaction. The reaction generated heat that activated additional sprinkler heads, causing water to contact additional chlorinated isocyanurates and other chemicals. The resulting reactions generated additional heat, contributing to further decomposition, toxic vapors, smoke, and fires.

CSB-Identified Safety Issues and Regulatory Gaps

The CSB identified several safety issues contributing to the incident, including Bio-Lab’s approach to maintaining its corroding sprinkler system and its failure to adequately identify hazards associated with storing chlorinated isocyanurates.

The CSB also found gaps in PSM and RMP coverage of reactive hazards. The reactive chemicals stored at the facility fell outside PSM and RMP. Had the company’s storage of these materials been covered, Bio-Lab would have been required to implement hazard-assessment, prevention, and mitigation measures to reduce the likelihood or severity of an incident. Although other safety requirements and standards applied to aspects of Bio-Lab’s operations, the CSB concluded that the incident illustrates a broader gap in how PSM and RMP address reactive hazards.

The fact that Bio-Lab was not covered by PSM did not mean it was entirely unregulated by OSHA, however. The CSB explains that the storage and handling of chlorinated isocyanurates and bromochloro-5,5-dimethylimidazolidine-2,4-dione (BCDMH) remained subject to OSHA’s General Duty Clause.

OSHA also issued citations involving HAZWOPER, 29 C.F.R. § 1910.120, and the Respiratory Protection standard, 29 C.F.R. § 1910.134. According to the CSB report, OSHA issued six citations totaling $61,473, which had been paid by the time the report was published.

CSB Recommendations

The CSB recommended that OSHA amend the PSM standard to more comprehensively address reactive chemical hazards capable of causing catastrophic incidents. The CSB identified a similar regulatory gap under EPA’s RMP rule. Specifically, it advised that EPA revise the RMP regulations to explicitly cover catastrophic reactive hazards capable of seriously affecting the public, including hazards arising from:

  • self-reactive chemicals;
  • combinations of chemicals; and
  • process-specific conditions.
What This Means for Chemical Manufacturers and Facilities that Use Chemicals in Manufacturing

CSB notes that facilities storing, using, and manufacturing hazardous chemicals have an obligation not only to understand the full hazards and risks associated with the chemicals, but to effectively assess and manage the risks inherent in the storage and handling of these materials to avoid the occurrence of an incident. A key lesson highlighted in the report states, “Even in the absence of regulatory requirements for risk assessments, organizations should ensure that all hazards of using and storing hazardous chemicals be assessed and properly mitigated.”